CSIMarket
 


Idexx Laboratories Inc  (IDXX)
Other Ticker:  
 


Idexx Laboratories Inc's ROI from its second quarter of 2024 to the second quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Idexx Laboratories Inc's ROI in the second quarter of 2024?
Idexx Laboratories Inc achieved a return on average invested assets (ROI) of 37.09 % in its second quarter of 2024, which is below Idexx Laboratories Inc's average return on investment, which stands at 126.44%.

ROI decreased relative to the period ending Mar 31 2024, due to the decline in net income.

Within the Healthcare sector 4 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2024 quarter, so far to 28, from total ROI ranking in the first quarter of 2024 at 89.

Definition and Formula of Return on Investment


Return On Investment (Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
Y / Y Investment Change TTM 36.3 % 43.35 % 35.38 % 18.93 % 3.12 %
Y / Y Net Income Change TTM 6.85 % 23.94 % 74.19 % 162.92 % 499.67 %
Investment (TTM) in Millions 2,298 2,397 2,308 2,116 1,987
Return On Investment (TTM) 37.09 % 39.35 % 41.45 % 44.73 % 47.31 %
IDXX's Overall Ranking # 28 # 89 # 34 # 88 # 96
Seq. Investment Change TTM 3.53 % 8.02 % 10.84 % 9.96 % 8.89 %
Seq. Net Income Change TTM -2.42 % 2.55 % 2.71 % 3.95 % 13.2 %
Net Income (TTM) in Millions 846 867 845 823 791




Return On Investment IDXX's Ranking
Within: No.
Industry # 0
Sector # 5
Overall # 28

Return On Investment Statistics
High Average Low
747.86 %
126.44 %
28.92 %
(Sep 30 2017)   (Dec 31 2013)







Financial Statements
Idexx Laboratories Inc's II. Quarter Investments $ 2,298 Millions IDXX's Balance sheet
Idexx Laboratories Inc's II. Quarter Income $ 203 Millions Quarterly IDXX's Income Statement
IDXX's Income by Division See IDXX's Income by Division


IDXX Annual Return On Investment (Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
Total Investments in Millions 2,308 1,511 1,674 1,713 1,107
Y / Y Investment Growth 52.78 % -9.72 % -2.27 % 54.63 % 63.53 %
Net Income in Millions 845 679 745 582 428
Y / Y Net Income Growth 24.44 % -8.83 % 27.95 % 36.08 % 13.46 %
Annual Return On Investment 36.61 % 44.94 % 44.5 % 33.99 % 38.63 %


Annual Roi Comment
In the fiscal year 2023 ROI deteriorated to 36.61 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
In Vitro & In Vivo Diagnostic Substances Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
IDXX's Roi Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Return On Investment for IDXX's Competitors
Roi for Idexx Laboratories Inc's Suppliers
Return On Investment for IDXX's Customers

Other Ratios
IDXX's Roa IDXX's Inventory Turnover Ratio IDXX's Growth Rates IDXX's Dividend Statistics
IDXX's Profitability Ratios IDXX's Asset Turnover Ratio IDXX's Dividend Growth
IDXX's Roe IDXX's Valuation Ratios IDXX's Financial Strength Ratios IDXX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2024, within Healthcare Sector ROI
  83.12 %
Roivant Sciences Ltd   77.21 %
Sharps Technology Inc   65.50 %
Kaya Holdings Inc   60.16 %
Guardion Health Sciences Inc   55.97 %
Mimedx Group Inc   52.15 %
Tevogen Bio Holdings Inc   51.46 %
Entrada Therapeutics Inc   50.42 %
Siga Technologies Inc  50.32 %
Dariohealth Corp   50.05 %
Protagonist Therapeutics inc   37.74 %
National Research Corporation  37.64 %
Pharmacyte Biotech Inc   37.58 %
Mettler Toledo International Inc  36.92 %
Medpace Holdings Inc   36.84 %
Idexx Laboratories Inc  36.50 %
Quince Therapeutics Inc   33.71 %
Exelixis Inc   32.02 %
Elite Pharmaceuticals Inc   31.13 %
Johnson and Johnson  30.31 %
Lantheus Holdings Inc   28.19 %
Carlisle Companies Incorporated  25.58 %
Tg Therapeutics Inc   25.31 %
Iradimed Corporation  23.13 %
Corcept Therapeutics Inc  23.12 %
Cardiff Lexington Corporation  22.21 %
Semler Scientific inc   21.17 %
Cassava Sciences Inc  20.29 %
Chemed Corporation  20.22 %
Kewaunee Scientific Corporation  19.98 %


Date modified: 2024-09-13T05:34:48+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com